Quote:
Originally Posted by justplugit
Why will Pharma research and develop new antibiotics if they can't make a decent profit.
|
Last time I checked, a few years ago, the average margin on Pharma was around 25%...that's not a bad profit.
Two opposing factors:
1) The current pharma environment drives companies to invest in category killer drugs that will produce massive returns.
2) The potential for litigation will prevent companies from moving on high-risk R&D investments.
So there's a lot more $$$ by producing the next Viagra rather than the staph-killing antibiotic that will rot 1 in 10:000's organs.
-spence